Results 1 to 10 of about 5,953 (211)

PEGylation in Anti-Cancer Therapy: An Overview

open access: yesAsian Journal of Pharmaceutical Sciences, 2016
Advanced drug delivery systems using poly(ethylene glycol) (PEG) is an important development in anti-cancer therapy. PEGylation has the ability to enhance the retention time of the therapeutics like proteins, enzymes small molecular drugs, liposomes and ...
Ratan Kumar Dey   +2 more
exaly   +3 more sources

PEGylated therapeutics in the clinic

open access: yesBioengineering & Translational Medicine, 2023
The covalent attachment of polyethylene glycol (PEG) to therapeutic agents, termed PEGylation, is a well‐established and clinically proven drug delivery approach to improve the pharmacokinetics and pharmacodynamics of drugs.
Yongsheng Gao   +3 more
doaj   +3 more sources

Shrinkage of pegylated and non-pegylated liposomes in serum [PDF]

open access: yesColloids and Surfaces B: Biointerfaces, 2014
An essential requisite for the design of nanodelivery systems is the ability to characterize the size, homogeneity and zeta potential of nanoparticles. Such properties can be tailored in order to create the most efficient drug delivery platforms. An important question is whether these characteristics change upon systemic injection.
Wolfram J   +8 more
  +9 more sources

DEVELOPMENT OF DELIVERY SYSTEM FOR TRANSFERRIN USING CHEMICAL MODIFICATION APPROACH [PDF]

open access: yesBasrah Journal of Veterinary Research, 2012
Proteins are very important molecules as therapeutics. They have several advantages over small molecule drugs but their use is limited by their circulation short half life, immunogenicity and physicochemical instability.
Athmar D. Habeeb
doaj   +1 more source

To PEGylate or Not To PEGylate Therapeutics? [PDF]

open access: yesCell Chemical Biology, 2019
PEGylation is a common modulator of pharmacokinetics for therapeutic agents in vivo. In this issue of Cell Chemical Biology, Moreno et al. (2019) show anti-PEG antibodies may directly inhibit the activity of a PEGylated aptamer, RB006, both in vitro and in vivo, and the issues surrounding anti-PEG antibodies are discussed.
Keith E, Maier   +2 more
openaire   +2 more sources

Optimization of Ultra-Small Nanoparticles for Enhanced Drug Delivery

open access: yesBIO Integration, 2023
Nanoparticle delivery of drugs to the brain is hindered by the blood-brain barrier (BBB). In malignant glioma (MG), small disruptions in the BBB may allow nanoparticles smaller than 20 nm to penetrate the dysfunctional barrier.
Shishi He   +7 more
doaj   +1 more source

A novel solid-phase site-specific PEGylation enhances the in vitro and in vivo biostabilty of recombinant human keratinocyte growth factor 1. [PDF]

open access: yesPLoS ONE, 2012
Keratinocyte growth factor 1 (KGF-1) has proven useful in the treatment of pathologies associated with dermal adnexae, liver, lung, and the gastrointestinal tract diseases. However, poor stability and short plasma half-life of the protein have restricted
Zhifeng Huang   +9 more
doaj   +1 more source

Investigation of Cytotoxic Effects of Recombinant Human Interferon Lambda-1 and Its Pegylated Form on Human Conjunctival Epithelial Cells

open access: yesБезопасность и риск фармакотерапии, 2021
Currently, there are no efficacious, all-purpose antiviral medicines for the treatment of ocular surface infections caused by viruses. At the same time, type III interferons demonstrate high potency for histological barriers, such as the conjunctiva ...
N. A. Kikhtenko   +6 more
doaj   +1 more source

BF2-Azadipyrromethene Fluorophores for Intraoperative Vital Structure Identification

open access: yesMolecules, 2023
A series of mono- and bis-polyethylene glycol (PEG)-substituted BF2-azadipyrromethene fluorophores have been synthesized with emissions in the near-infrared region (700–800 nm) for the purpose of fluorescence guided intraoperative imaging; chiefly ureter
Cathal Caulfield   +14 more
doaj   +1 more source

PEGylated Systems in Pharmaceutics [PDF]

open access: yesPolymer Science, Series C, 2020
This review addresses the use of poly(ethylene glycol) (PEG) and PEG conjugation for the design of novel dosage forms and the modification of biomolecules. The peculiarities of PEGylated nanoparticles, liposomes, proteins, enzymes, and small drug and polyelectrolyte molecules and their influence on systemic drug delivery, including overcoming of ...
Porfiryeva, N. N.   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy